---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-008934"
form_type: "8-K"
ticker: "TNYA"
cik: "0001858848"
company_name: "Tenaya Therapeutics, Inc."
filed_at: "2023-03-21T23:59:59+00:00"
generated_at: "2026-06-17T22:33:25.430530+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Tenaya Therapeutics adopts amended bylaws with enhanced stockholder nomination procedures

## Summary
- Enhanced disclosure requirements for stockholder director nominations and business proposals.
- Updated provisions to address universal proxy rules and conform to Delaware General Corporation Law amendments.
- Revised procedures for stockholder meetings, quorum, and adjourned meetings.
- Clarified exclusive forum provisions and updated director, committee, and officer sections.

## SEC filing metadata
- accession: 0000950170-23-008934
- form_type: 8-K
- ticker: TNYA
- cik: 0001858848
- company_name: Tenaya Therapeutics, Inc.
- filed_at: 2023-03-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858848/000095017023008934/0000950170-23-008934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858848/000095017023008934/tnya-20230316.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-008934
- JSON: https://secwatch.observer/filing/0000950170-23-008934.json
- Plain text: https://secwatch.observer/filing/0000950170-23-008934.txt

## Key facts
- Governance Changes
  Tenaya Therapeutics, Inc.: Amended and restated bylaws to enhance procedural mechanics for stockholder nominations and other business, update DGCL provisions, and make other updates (effective 2023-03-16).
  - Change: bylaw amendment
  - Effective: 2023-03-16
  source text: On March 16, 2023, the Board of Directors (the “Board”) of Tenaya Therapeutics, Inc. (“Tenaya”) approved Tenaya’s Amended and Restated Bylaws (the “Amended and Restated Bylaws”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858848/000095017023008934/0000950170-23-008934-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.